Comparing 1 vs 2 Hours Post Meal Glucose Monitoring in Gestational Diabetes
1 Versus 2 Hours Post Meal Self Monitoring Blood Glucose in Gestational Diabetes Mellitus on Treatment-A Prospective Randomised Controlled Trial
This study is testing whether checking blood sugar levels 1 hour or 2 hours after meals helps pregnant women with gestational diabetes manage their condition better.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 2954 (estimated) |
| Ages | 18 Years to 45 Years |
| Sex | Female |
| Sponsor | National University of Malaysia Academic / other |
| Locations | 1 site (Kuala Lumpur, W.Persekutuan) |
| Trial ID | NCT05326204 on ClinicalTrials.gov |
What this trial studies
This study compares the effectiveness of monitoring blood glucose levels 1 hour versus 2 hours after meals in pregnant women diagnosed with Gestational Diabetes Mellitus who require treatment. Participants will be randomly assigned to one of the two monitoring schedules and will undergo a staggered 7-point blood sugar profile. The study aims to follow these patients until delivery to assess treatment adherence and glucose control.
Who should consider this trial
Good fit: Ideal candidates are pregnant women diagnosed with gestational diabetes who require treatment with metformin or insulin.
Not a fit: Patients with type 1 or type 2 diabetes, a history of poor obstetric outcomes, or other significant medical conditions may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could help optimize glucose monitoring practices for pregnant women with gestational diabetes, leading to better health outcomes for both mothers and babies.
How similar studies have performed: Other studies have explored glucose monitoring in gestational diabetes, but this specific comparison of monitoring times is less common and may provide novel insights.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Gestational diabetes diagnosed based on National Institute for Health and Care Excellence guideline * requiring treatment either with metformin alone or combined with insulin Exclusion Criteria: * type 1 and 2 diabetes * bad obstetrics history * underlying medical disorders such as Systemic Lupus Erythematosus * fetal anomaly * delivery elsewhere
Where this trial is running
Kuala Lumpur, W.Persekutuan
- UKM Medical Center — Kuala Lumpur, W.Persekutuan, Malaysia (Recruiting)
Study contacts
- Principal investigator: Rahana Abd Rahman — National University of Malaysia
- Study coordinator: Rahana Abd Rahman
- Email: drrahana@ppukm.ukm.edu.my
- Phone: +60122719985
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.